| 000 -LEADER |
|---|
| fixed length control field |
01122cam a2200265 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190826131121.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
080305s2008 enkaf b 101 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780470723258 (hbk.) |
| 041 0# - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC661.I55 |
| Item number |
D44 2008 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.46206 |
| Edition number |
22 |
| Item number |
D313 |
| 245 00 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Defining optimal immunotherapies for type 1 diabetes / |
| Statement of responsibility, etc |
[editors: Gregory Bock and Jamie Goode] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Chichester, England : |
| Name of publisher, distributor, etc |
Wiley-Blackwell, |
| Date of publication, distribution, etc |
2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
ix, 212 p., [1] leaf of plates : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
24 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| 9 (RLIN) |
13644 |
| Title |
Novartis Foundation symposium ; |
| Volume number/sequential designation |
292 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Papers from the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Diabetes |
| General subdivision |
Immunotherapy |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
21404 |
|
|---|
| Topical term or geographic name as entry element |
Diabetes Mellitus, Type 1 |
| General subdivision |
therapy |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
21405 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bock, Gregory. |
| 9 (RLIN) |
2056 |
| Relator term |
editor |
|
|---|
| Personal name |
Goode, Jamie. |
| Relator term |
editor |
| 9 (RLIN) |
44263 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Novartis Foundation. |
| 9 (RLIN) |
2058 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
